• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠c-abl原癌基因的激活:一个点突变对致癌激活的影响。

Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.

作者信息

Shore S K, Bogart S L, Reddy E P

机构信息

Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104-4268.

出版信息

Proc Natl Acad Sci U S A. 1990 Sep;87(17):6502-6. doi: 10.1073/pnas.87.17.6502.

DOI:10.1073/pnas.87.17.6502
PMID:2168550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC54564/
Abstract

Activation of the c-abl protooncogene occurs in Abelson murine leukemia virus, in Hardy-Zuckerman 2 feline sarcoma virus, and during the chromosomal translocations that generate BCR-ABL gene fusion products. To study the molecular mechanism involved in the c-abl activation, we have created a series of modifications in murine c-abl and assayed these constructs for oncogenic activity using the NIH 3T3 cell transformation assay. Our results show that amino-terminal deletions are sufficient for oncogenic activation of c-abl and high levels of oncogenic activities were generated by a deletion of 114 codons from the 5' end that deleted the SH3 region. A deletion of 53 codons from the 5' end (inclusive of deletions seen in Hardy-Zuckerman 2 feline sarcoma virus and BCR-ABL gene products) that retains the SH3 region of c-abl resulted in the generation of low levels of transforming activity. This transforming potential was substantially increased with the introduction of a G----A point mutation in codon 832 that is present in v-abl. The point mutation was found to affect the secondary structure and the tyrosine kinase activity of the mutant gene products.

摘要

c-abl原癌基因的激活发生在艾贝尔逊鼠白血病病毒、哈迪-祖克曼2型猫肉瘤病毒中,以及在产生BCR-ABL基因融合产物的染色体易位过程中。为了研究c-abl激活所涉及的分子机制,我们对鼠c-abl进行了一系列修饰,并使用NIH 3T3细胞转化试验检测这些构建体的致癌活性。我们的结果表明,氨基末端缺失足以使c-abl致癌激活,并且从5'端缺失114个密码子(该缺失删除了SH3区域)产生了高水平的致癌活性。从5'端缺失53个密码子(包括在哈迪-祖克曼2型猫肉瘤病毒和BCR-ABL基因产物中所见的缺失),保留了c-abl的SH3区域,导致产生低水平的转化活性。随着在v-abl中存在的第832位密码子引入G→A点突变,这种转化潜能大幅增加。发现该点突变影响突变基因产物的二级结构和酪氨酸激酶活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/d9cf8ecc3ab5/pnas01042-0038-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/9f7c8c3382ef/pnas01042-0036-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/4e0acb26e220/pnas01042-0037-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/46dbde775e23/pnas01042-0037-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/426d2e3a8a4a/pnas01042-0037-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/ca98bd11059e/pnas01042-0037-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/161d99b9b687/pnas01042-0037-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/998fd306720e/pnas01042-0037-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/45ea1298e02e/pnas01042-0037-g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/07dcbea1bc51/pnas01042-0037-h.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/6360f8b1706d/pnas01042-0038-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/d9cf8ecc3ab5/pnas01042-0038-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/9f7c8c3382ef/pnas01042-0036-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/4e0acb26e220/pnas01042-0037-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/46dbde775e23/pnas01042-0037-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/426d2e3a8a4a/pnas01042-0037-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/ca98bd11059e/pnas01042-0037-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/161d99b9b687/pnas01042-0037-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/998fd306720e/pnas01042-0037-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/45ea1298e02e/pnas01042-0037-g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/07dcbea1bc51/pnas01042-0037-h.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/6360f8b1706d/pnas01042-0038-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ddb/54564/d9cf8ecc3ab5/pnas01042-0038-b.jpg

相似文献

1
Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.小鼠c-abl原癌基因的激活:一个点突变对致癌激活的影响。
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6502-6. doi: 10.1073/pnas.87.17.6502.
2
bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.bcr/abl和src而非myc和ras在淋巴样转化中取代了v-abl。
Mol Cell Biol. 1990 Aug;10(8):4365-9. doi: 10.1128/mcb.10.8.4365-4369.1990.
3
Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.费城染色体阳性白血病:易位基因及其基因产物
Baillieres Clin Haematol. 1992 Oct;5(4):897-930. doi: 10.1016/s0950-3536(11)80051-x.
4
Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential.c-abl酪氨酸激酶N端调控结构域的缺失激活了其致癌潜能。
EMBO J. 1989 Jan;8(1):137-47. doi: 10.1002/j.1460-2075.1989.tb03358.x.
5
Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.abl癌基因的激活及其在人类白血病染色体易位中的作用。
Mutat Res. 1988 May;195(3):231-43. doi: 10.1016/0165-1110(88)90002-4.
6
N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.N 端突变激活了肉豆蔻酰化形式的 c-abl 的致白血病潜能。
EMBO J. 1989 Feb;8(2):449-56. doi: 10.1002/j.1460-2075.1989.tb03397.x.
7
Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.黑腹果蝇abl蛋白和鼠类v-abl蛋白在哺乳动物细胞转化中的功能保守性。
J Virol. 1990 May;64(5):2226-35. doi: 10.1128/JVI.64.5.2226-2235.1990.
8
Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.缺乏蛋白酪氨酸激酶活性的阿贝尔逊鼠白血病病毒温度敏感突变体。
J Virol. 1990 Sep;64(9):4242-51. doi: 10.1128/JVI.64.9.4242-4251.1990.
9
Structures and activities of activated abl oncogenes.活化的abl癌基因的结构与活性
Curr Top Microbiol Immunol. 1989;147:129-53. doi: 10.1007/978-3-642-74697-0_4.
10
Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.含SH3结构域的酪氨酸激酶中保守的苯丙氨酸突变激活了c-Abl的转化能力。
Oncogene. 1993 Jul;8(7):1943-56.

引用本文的文献

1
Oenological Characteristics of Four Non- Yeast Strains With -Glycosidase Activity.四种具有β-糖苷酶活性的非酵母菌株的酿酒学特性
Front Microbiol. 2021 Sep 3;12:626920. doi: 10.3389/fmicb.2021.626920. eCollection 2021.
2
An activating amino acid substitution in the c-abl oncogene protein fails to produce a local conformational change.c-abl癌基因蛋白中的一个激活氨基酸取代未能产生局部构象变化。
J Protein Chem. 1991 Aug;10(4):437-41. doi: 10.1007/BF01025258.
3
Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.

本文引用的文献

1
Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro.烯醇化酶和乳酸脱氢酶中酪氨酸蛋白激酶在体内和体外利用的磷酸化位点。
J Biol Chem. 1984 Jun 25;259(12):7835-41.
2
Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia.慢性粒细胞白血病中与易位断点相邻的c-ab1癌基因的定位。
Nature. 1983;306(5940):239-42. doi: 10.1038/306239a0.
3
The Hardy-Zuckerman 2-FeSV, a new feline retrovirus with oncogene homology to Abelson-MuLV.哈代-朱克曼2型猫肉瘤病毒,一种与阿贝尔森鼠白血病病毒具有癌基因同源性的新型猫逆转录病毒。
bcr/abl融合蛋白中的bcr序列激活酪氨酸激酶以及c-abl的微丝结合功能。
Mol Cell Biol. 1991 Mar;11(3):1553-65. doi: 10.1128/mcb.11.3.1553-1565.1991.
Nature. 1983 Jun 30;303(5920):825-8. doi: 10.1038/303825a0.
4
Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.阿贝尔逊鼠白血病病毒基因组的核苷酸序列:其转化基因产物与其他具有酪氨酸特异性激酶活性的癌基因产物的结构相似性。
Proc Natl Acad Sci U S A. 1983 Jun;80(12):3623-7. doi: 10.1073/pnas.80.12.3623.
5
Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA.阿贝尔逊鼠白血病病毒基因组及同源细胞基因的结构:对克隆病毒DNA的研究
Cell. 1980 Dec;22(3):777-85. doi: 10.1016/0092-8674(80)90554-1.
6
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine.阿贝尔逊鼠白血病病毒蛋白在体外被磷酸化形成磷酸酪氨酸。
Nature. 1980 Feb 28;283(5750):826-31. doi: 10.1038/283826a0.
7
An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.K562白血病细胞中人类c-abl蛋白的改变揭示了相关的酪氨酸激酶活性。
Cell. 1984 Jul;37(3):1035-42. doi: 10.1016/0092-8674(84)90438-0.
8
Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products.体外检测c-abl酪氨酸激酶活性可直接比较正常和变异的abl基因产物。
Mol Cell Biol. 1985 Nov;5(11):3116-23. doi: 10.1128/mcb.5.11.3116-3123.1985.
9
In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.费城染色体的P210 BCR/ABL癌基因产物对未成熟造血细胞的体外转化
Proc Natl Acad Sci U S A. 1987 Sep;84(18):6558-62. doi: 10.1073/pnas.84.18.6558.
10
Nucleotide sequence of testis-derived c-abl cDNAs: implications for testis-specific transcription and abl oncogene activation.睾丸来源的c-abl cDNA的核苷酸序列:对睾丸特异性转录和abl癌基因激活的影响。
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8200-4. doi: 10.1073/pnas.84.23.8200.